Practice Guideline

. 2021 Feb;32(2):142-156.

doi: 10.1016/j.annonc.2020.11.002. Epub 2020 Nov 19.

Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up^†☆

P Fenaux¹, D Haase², V Santini³, G F Sanz⁴, U Platzbecker⁵, U Mey⁶; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org

Affiliations

¹ Service d'Hématologie Clinique, Groupe Francophone des Myélodysplasies (GFM), Department of Hematology, Hôpital St. Louis (Assistance Publique, Hôpitaux de Paris), Paris, France; Paris 7 University, Paris, France.
² Department of Hematology and Medical Oncology, University Medical Center, Göttingen, Germany.
³ MDS Unit, Haematology, AOU Careggi, University of Florence, Florence, Italy.
⁴ Department of Haematology, Hospital Universitario La Fe, Valencia, Spain; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.
⁵ Department of Hematology and Cellular Therapy, Medical Clinic and Policlinic 1, University Hospital Leipzig, Germany.
⁶ Department of Oncology and Haematology, Kantonsspital Graubuenden, Chur, Switzerland.

PMID: 33221366
DOI: 10.1016/j.annonc.2020.11.002

Free article

Practice Guideline

Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up^†☆

P Fenaux et al. Ann Oncol. 2021 Feb.

Free article

. 2021 Feb;32(2):142-156.

doi: 10.1016/j.annonc.2020.11.002. Epub 2020 Nov 19.

Authors

P Fenaux¹, D Haase², V Santini³, G F Sanz⁴, U Platzbecker⁵, U Mey⁶; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org

Affiliations

¹ Service d'Hématologie Clinique, Groupe Francophone des Myélodysplasies (GFM), Department of Hematology, Hôpital St. Louis (Assistance Publique, Hôpitaux de Paris), Paris, France; Paris 7 University, Paris, France.
² Department of Hematology and Medical Oncology, University Medical Center, Göttingen, Germany.
³ MDS Unit, Haematology, AOU Careggi, University of Florence, Florence, Italy.
⁴ Department of Haematology, Hospital Universitario La Fe, Valencia, Spain; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.
⁵ Department of Hematology and Cellular Therapy, Medical Clinic and Policlinic 1, University Hospital Leipzig, Germany.
⁶ Department of Oncology and Haematology, Kantonsspital Graubuenden, Chur, Switzerland.

PMID: 33221366
DOI: 10.1016/j.annonc.2020.11.002

No abstract available

Keywords: Clinical Practice Guidelines; Myelodysplastic syndromes; diagnosis; follow-up; treatment.

PubMed Disclaimer

Conflict of interest statement

Disclosure PF has received honoraria and/or research support from Celgene, Janssen, AbbVie, Jazz, Novartis, Roche and Aprea; GFS has received honoraria from and/or played an advisory role for AbbVie, Amgen, Böehringer Ingelheim, Celgene, Helsinn Healthcare, Roche, Janssen-Cilag, Novartis, Takeda and Onconova; VS has received honoraria from Astex, Celgene, Novartis, Pfizer, Janssen-Cilag and Takeda; UP has received honoraria and/or research support from Celgene, Janssen, AbbVie, Jazz, Novartis and Amgen; DH has received honoraria from Celgene, Novartis and Takeda, and research support from Novartis and Celgene; UM has reported honoraria from Celgene, Roche and Amgen.

Cited by

Adverse Events in 1406 Patients Receiving 13,780 Cycles of Azacitidine within the Austrian Registry of Hypomethylating Agents-A Prospective Cohort Study of the AGMT Study-Group.
Leisch M, Pfeilstöcker M, Stauder R, Heibl S, Sill H, Girschikofsky M, Stampfl-Mattersberger M, Tinchon C, Hartmann B, Petzer A, Schreder M, Kiesl D, Vallet S, Egle A, Melchardt T, Piringer G, Zebisch A, Machherndl-Spandl S, Wolf D, Keil F, Drost M, Greil R, Pleyer L. Leisch M, et al. Cancers (Basel). 2022 May 17;14(10):2459. doi: 10.3390/cancers14102459. Cancers (Basel). 2022. PMID: 35626063 Free PMC article.
Management of infection prophylaxis in Dutch patients with myelodysplastic syndromes, a web-based case vignette questionnaire: The MINDSET study.
Rozema J, van Roon E, Vogelzang L, Kibbelaar R, Veeger N, van de Loosdrecht A, Hoogendoorn M. Rozema J, et al. Eur J Haematol. 2022 Oct;109(4):381-387. doi: 10.1111/ejh.13820. Epub 2022 Jul 6. Eur J Haematol. 2022. PMID: 35753043 Free PMC article.
Allogeneic hematopoietic cell transplantation in elderly patients with myelodysplastic syndromes: Considerations and challenges.
Schulz E, Pavletic SZ, Mina A. Schulz E, et al. Semin Hematol. 2024 Dec;61(6):420-430. doi: 10.1053/j.seminhematol.2024.10.004. Epub 2024 Oct 17. Semin Hematol. 2024. PMID: 39523201 Review.
Association between transfusion status and clinical and economic outcomes in patients with myelodysplastic syndromes from the physicians' perspective.
Gupta S, Kulasekararaj AG, Costantino H, Grisolano J, Tang J, Jones S, Tang D. Gupta S, et al. Cancer Rep (Hoboken). 2023 Jan;6(1):e1680. doi: 10.1002/cnr2.1680. Epub 2022 Aug 9. Cancer Rep (Hoboken). 2023. PMID: 35942648 Free PMC article.
Moving toward a conceptualization of measurable residual disease in myelodysplastic syndromes.
Schulz E, Aplan PD, Freeman SD, Pavletic SZ. Schulz E, et al. Blood Adv. 2023 Aug 22;7(16):4381-4394. doi: 10.1182/bloodadvances.2023010098. Blood Adv. 2023. PMID: 37267435 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up^†☆

Affiliations

Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up^†☆

Authors

Affiliations

Conflict of interest statement

Similar articles

Cited by

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Conflict of interest statement

Similar articles

Cited by

Publication types

MeSH terms

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical